top of page

Lenvima 4 mg Capsule

SKU Eisai Pharmaceuticals India Pvt Ltd
Precio original

133,39$

Precio de oferta

122,53$

Lenvima 4 mg capsule is a targeted therapy specifically designed to combat various forms of cancer, including advanced thyroid cancer that has recurred or metastasized, renal cell carcinoma in patients who have undergone prior chemotherapy, and hepatocellular carcinoma unsuitable for surgical intervention. Additionally, it is effective for endometrial cancer that has progressed post-chemotherapy or is unmanageable through surgery or radiation. As a potent kinase inhibitor, Lenvima operates by disrupting the signaling pathways of abnormal proteins that promote cancer cell proliferation, thereby hindering tumor growth and dissemination. Patients should be aware of potential side effects, which may include fatigue, hypertension, and gastrointestinal disturbances, necessitating regular monitoring by healthcare professionals. Prior to initiating treatment, it’s crucial to discuss any existing medical conditions or medications with your doctor to ensure safe use. With its innovative mechanism and focused application, Lenvima 4 mg serves as an essential option in the oncologist's arsenal against aggressive cancer types. Always consult with your healthcare provider for personalized advice and to understand the full spectrum of benefits and risks associated with Lenvima.

Cantidad

Active Pharmaceutical Ingredient

Lenvatinib 4 mg

Uses

• Lenvima 4 mg capsule is primarily indicated for the treatment of thyroid cancer that has recurred or metastasized and is unresponsive to radioactive iodine therapy. In these cases, Lenvima helps to inhibit tumor growth by targeting specific pathways involved in cancer progression. Patients experiencing advanced thyroid cancer may find Lenvima 4 mg to be an effective option to manage their condition. The medication aims to improve overall survival rates and quality of life.
• Lenvima 4 mg capsule is also utilized in the management of advanced renal cell carcinoma (RCC) in adults. This treatment is typically combined with everolimus for patients who have previously undergone chemotherapy. Lenvima works by interfering with the cancer cell's ability to grow and divide, providing a critical therapeutic strategy for those with advanced kidney cancer. The use of Lenvima 4 mg can help prolong survival in this challenging diagnosis.
• For individuals diagnosed with hepatocellular carcinoma (HCC), Lenvima 4 mg capsule serves as a viable treatment option, especially when surgical interventions are not feasible. HCC is the most common form of liver cancer, and Lenvima helps to slow disease progression. By targeting the underlying mechanisms of tumor growth, Lenvima 4 mg can provide symptomatic relief and help manage the disease effectively. This makes it an important medication in the oncology landscape for liver cancer management.

Benefits

Lenvima 4 mg Capsule works by targeting specific proteins that play a role in the growth and spread of cancer cells, thereby potentially slowing down or halting the progression of the tumour. Lenvima 4 is effective in treating certain types of cancer, such as thyroid cancer and kidney cancer, and in some cases, it can shrink tumours or reduce the symptoms associated with the disease. Lenvima 4 mg may cause fewer side effects compared to traditional chemotherapy and taken orally, which makes it easy to take and convenient for patients. Lenvima 4 mg Capsule can be used as a long-term treatment option for patients with advanced cancer, which can help to improve their quality of life and extend their lifespan.

Side Effects

Like all medication, Lenvima 4 mg Capsule may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects

• Hoarse Voice
• Low or High Blood Pressure
• Hair Loss
• Swelling of Legs
• Tiredness
• Vomiting
• Nausea
• Indigestion
• Pain in Muscle and Joints

Common Side Effects

• Breathing Problems
• Blood Clot
• Dizziness
• Fever
• Bloody Stool
• Vision Problems
• Speaking Difficulty

How To Use

Lenvima 4 mg Capsule can be taken with or without food, but it is recommended to take it at the same time each day for optimal results. Dosage and frequency of use will be determined by your doctor based on your specific condition and may change over time. It is important that you follow your doctor's instructions and do not change the dosage or frequency of intake without their guidance.

Safety Advice

• Alcohol: It is not recommended to consume alcohol while taking Lenvima 4 mg Capsule. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Lenvima 4 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Lenvima 4 mg Capsule should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Lenvima 4 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of Lenvima 4 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Lenvima 4 mg. Lenvima 4 mg Capsule may pass into breast milk and harm the infant. If you are breastfeeding and taking Lenvima 4 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Lenvima 4 mg Capsule should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Lenvima 4 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Lenvima 4 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Lenvima 4 mg Capsule may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Lenvima 4 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Lenvima 4 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Lenvima 4 mg.

bottom of page